In order to further protect the medication safety for the public, NMPA decided to revise the package inserts of 14 drug varieties including the Paracetamol, Pseudoephedrine Hydrochloride and Dextromethorphan Hydrobromide Oral Solution, Paracetamol, Pseudoephedrine Hydrochloride and Dextromethorphan Hydrobromide Syrup, Pediatric Paracetamol and Amantadine Hydrochloride Granules, Paracetamol, Pseudoephedrine Hydrochloride and Chlorpheniramine Maleate Chewable Tablets, Pediatric Compound Paracetamol and Amantadine Hydrochloride Tablets, Pediatric Paracetamol, Caffein, Artificial Cow-bezoar and Chlorphenamine Maleate Granules, Paracetamol, Amantadine Hydrochloride, Artificial Cow-bezar and Chlorphenamine Mdeate Granules, Paraceramol Caffeine Guaifenfsin and Chlorphenamine Maleate Solution, Pediatric Compound Paracetamol and Phenylephrine Tablets, Paracetamol, Caffeine, Artificial Cow-Bezoar, Chlorphenamine Maleate Oral Solution, Paracetamol, Pseudoephedrine Hydrochloride and Chlorphenamine Maleate Dispersible Tablets (III), Compound Paracetamol and Chlorphenamine Tablets for Infant, Pediatric Paracetamol, Artificial Cow-bezoar and Chlorphenamine Maleate Tablets, and Pediatric Paracetamol, Artificial Cow-bezoar and Chlorphenamine Maleate Granules.